These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33584070)

  • 1. Liver injury in the era of COVID-19.
    Cichoż-Lach H; Michalak A
    World J Gastroenterol; 2021 Feb; 27(5):377-390. PubMed ID: 33584070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.
    Lei HY; Ding YH; Nie K; Dong YM; Xu JH; Yang ML; Liu MQ; Wei L; Nasser MI; Xu LY; Zhu P; Zhao MY
    Biomed Pharmacother; 2021 Jan; 133():111064. PubMed ID: 33378966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cellular mechanisms of liver dysfunction in COVID-19.
    Huang C; Li Q; Xu W; Chen L
    Discov Med; 2020; 30(160):107-112. PubMed ID: 33382966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 induced hepatic injuries and liver complications.
    Saeed U; Piracha ZZ; Uppal SR; Waheed Y; Uppal R
    Front Cell Infect Microbiol; 2022; 12():726263. PubMed ID: 36189356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID 19 and liver: An A-Z literature review.
    Metawea MI; Yousif WI; Moheb I
    Dig Liver Dis; 2021 Feb; 53(2):146-152. PubMed ID: 32988758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
    Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
    Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury.
    Akkiz H
    Viruses; 2023 May; 15(6):. PubMed ID: 37376587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management.
    Li P; Liu Y; Cheng Z; Yu X; Li Y
    Biomed Pharmacother; 2022 Oct; 154():113568. PubMed ID: 36029543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney damage in COVID-19 patients.
    Chebotareva N; Berns S; Androsova T; Moiseev S
    Clin Nephrol; 2021 May; 95(5):227-239. PubMed ID: 33749581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?
    Michalak A; Lach T; Szczygieł K; Cichoż-Lach H
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of COVID-19 on the liver: The experience of a single center.
    Liakina V; Stundiene I; Milaknyte G; Bytautiene R; Reivytyte R; Puronaite R; Urbanoviciute G; Kazenaite E
    World J Gastroenterol; 2022 Oct; 28(39):5735-5749. PubMed ID: 36338891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
    Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
    Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant treatment in COVID-19: a narrative review.
    Carfora V; Spiniello G; Ricciolino R; Di Mauro M; Migliaccio MG; Mottola FF; Verde N; Coppola N;
    J Thromb Thrombolysis; 2021 Apr; 51(3):642-648. PubMed ID: 32809158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.